Reviewing Early-Stage NSCLC Treatments in 2025
Reviewing Early-Stage NSCLC Treatments in 2025

Deepa Rangachari, MD

Frontline Treatment for Metastatic EGFR-Mutated NSCLC
Frontline Treatment for Metastatic EGFR-Mutated NSCLC

Susan Scott, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

Selecting Up-Front Treatments for NSCLC with Targetable Mutations
Selecting Up-Front Treatments for NSCLC with Targetable Mutations

Susan Scott, MD

Recent and Upcoming Advancements in Treatment Options for SCLC
Recent and Upcoming Advancements in Treatment Options for SCLC

Ticiana Leal, MD

Frontline Treatment of Metastatic NSCLC Without Actionable Mutations
Frontline Treatment of Metastatic NSCLC Without Actionable Mutations

Mark Awad, MD, PhD